


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:49:36Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406328" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406328</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ejpt</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Psychotraumatol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Psychotraumatol</journal-id><journal-id journal-id-type="pmc-domain-id">1804</journal-id><journal-id journal-id-type="pmc-domain">ejpt</journal-id><journal-title-group><journal-title>European Journal of Psychotraumatology</journal-title></journal-title-group><issn pub-type="epub">2000-8066</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406328</article-id><article-id pub-id-type="pmcid-ver">PMC12406328.1</article-id><article-id pub-id-type="pmcaid">12406328</article-id><article-id pub-id-type="pmcaiid">12406328</article-id><article-id pub-id-type="pmid">40891431</article-id><article-id pub-id-type="doi">10.1080/20008066.2025.2545048</article-id><article-id pub-id-type="publisher-id">2545048</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research Article</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Feasibility of written exposure therapy for PTSD in a psychiatric outpatient clinic: in-person and remote delivery</article-title><trans-title-group xml:lang="es"><trans-title>Viabilidad de la terapia de exposici&#243;n escrita para el TEPT en una cl&#237;nica psiqui&#225;trica ambulatoria: presencial y a distancia</trans-title></trans-title-group><alt-title alt-title-type="right-running-head">EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY</alt-title><alt-title alt-title-type="left-running-head">H. HEDVALL ET AL.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hedvall</surname><given-names initials="H">Hannes</given-names></name><xref rid="AF1" ref-type="aff">a</xref><xref rid="an1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0088-8719</contrib-id><name name-style="western"><surname>Andersson</surname><given-names initials="E">Erik</given-names></name><xref rid="AF2" ref-type="aff">b</xref><xref rid="an1" ref-type="author-notes"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6349-0500</contrib-id><name name-style="western"><surname>Ivanov</surname><given-names initials="VZ">Volen Z.</given-names></name><xref rid="AF3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2246-3842</contrib-id><name name-style="western"><surname>Bragesj&#246;</surname><given-names initials="M">Maria</given-names></name><xref rid="AF3" ref-type="aff">c</xref><xref rid="cor1" ref-type="corresp"/></contrib><aff id="AF1"><label>a</label>Stockholm Health Care Services, <institution>Region Stockholm</institution>, <city>Stockholm</city>, <country>Sweden</country></aff><aff id="AF2"><label>b</label>Department of Clinical Neuroscience, Division of Psychology, <institution>Karolinska Institutet</institution>, <city>Stockholm</city>, <country>Sweden</country></aff><aff id="AF3"><label>c</label>Department of Clinical Neuroscience, <institution>Centre for Psychiatry Research, Karolinska Institutet, &amp; Stockholm Health Care Services</institution>, <city>Stockholm</city>, <country>Sweden</country></aff></contrib-group><author-notes><corresp id="cor1"><label>CONTACT</label> Maria Bragesj&#246; <email xlink:href="maria.bragesjo@ki.se">maria.bragesjo@ki.se</email> Department of Clinical Neuroscience, <institution>Centre for Psychiatry Research, Karolinska Institutet, &amp; Stockholm Health Care Services</institution>, <city>Stockholm</city>, <country>Sweden</country></corresp><fn id="an1"><label>*</label><p>H.H. and E.A. shared first authors.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><volume>16</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">478730</issue-id><elocation-id seq="215">2545048</elocation-id><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event><event event-type="received"><date><day>28</day><month>5</month><year>2025</year></date></event><event event-type="revised"><date><day>12</day><month>7</month><year>2025</year></date></event><event event-type="accepted"><date><day>4</day><month>8</month><year>2025</year></date></event><event event-type="tagger"><event-desc>Nova techset</event-desc><date><day>8</day><month>8</month><year>2025</year></date></event><event event-type="build-issue-online"><event-desc>Converted to JATS 1.2 by Nova Techset</event-desc><date><day>8</day><month>8</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="ZEPT_16_2545048.pdf"/><self-uri content-type="pdf" xlink:href="ZEPT_16_2545048.pdf"/><abstract><title>ABSTRACT</title><p><bold>Objectives:</bold> Previous trials have demonstrated that Written Exposure Therapy (WET) is effective in treating post-traumatic stress disorder (PTSD), achieving comparable outcomes to more time-intensive treatments such as prolonged exposure and cognitive processing therapy, but with lower dropout rates. Its short duration, absence of between-session homework, and high adherence rates make WET a promising alternative to traditional more time-intensive therapy. Despite established efficacy of WET in controlled trials, questions remain about its feasibility, tolerability, and flexibility when implemented in routine psychiatric outpatient settings. This study addresses these gaps.</p><p><bold>Method:</bold> Twenty-four patients, most with moderate to severe PTSD and significant psychiatric comorbidities, were recruited from a specialised psychiatric outpatient clinic for PTSD and underwent WET over a five-to-six-week period. Feasibility was assessed in terms of adherence, client satisfaction, adverse events, effectiveness, time requirements, and flexibility. PTSD symptom severity was measured at baseline, post-treatment, and one-month follow-up using the PTSD Checklist for DSM-5. The treatment was delivered either through face-to-face sessions at the clinic (<italic toggle="yes">n</italic>&#8201;=&#8201;7) or via video conferencing (<italic toggle="yes">n</italic>&#8201;=&#8201;15), with two participants receiving a combination of formats.</p><p><bold>Results:</bold> Adherence was high, with 23 of 24 participants completed treatment. Client satisfaction was excellent, with a mean score of 25.91 (SD&#8201;=&#8201;4.27) on the Client Satisfaction Questionnaire. Average therapist time required was under six hours per patient. Within-group analyses showed significant reductions in PTSD symptoms at one-month follow-up <italic toggle="yes">(d</italic>&#8201;=&#8201;1.08, 95% CI: 0.47&#8211;1.69). No serious adverse events were reported. WET was feasible, resource-efficient, video-compatible, and suitable for delivery by individual therapists with limited training.</p><p><bold>Conclusion:</bold> WET proved to be a feasible, effective, and resource-efficient intervention for PTSD in routine psychiatric care. Its implementation may expand access to evidence-based treatment and reduce reliance on full-dose CBT. Further research should explore its role in optimising care pathways and addressing waiting lists.</p><p><bold>Trial registration:</bold>
<related-object source-type="clinical-trials-registry" document-id-type="clinical-trial-number" document-id="NCT04328935" source-id-type="registry-name" source-id="ClinicalTrials.gov" xlink:href="https://clinicaltrials.gov/show/NCT04328935" id="d17812e186">ClinicalTrials.gov identifier: <ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT04328935">NCT04328935</ext-link></related-object>.</p></abstract><abstract abstract-type="plain-language-summary"><title>HIGHLIGHTS</title><p>
<list list-type="bullet"><list-item><p>Written Exposure Therapy (WET) was feasible and well-tolerated in a routine psychiatric outpatient setting, with high adherence and minimal therapist time.</p></list-item><list-item><p>The intervention led to significant reductions in PTSD and depressive symptoms, sustained at one-month follow-up.</p></list-item><list-item><p>WET was effectively delivered both in-person and via video, demonstrating flexibility and potential for broad clinical implementation.</p></list-item></list>
</p></abstract><trans-abstract xml:lang="es"><p><bold>Objetivos:</bold> Ensayos previos han demostrado que la Terapia de Exposici&#243;n Escrita (&#171;WET&#187;, por sus siglas en ingl&#233;s) es efectiva en el tratamiento del trastorno de estr&#233;s postraum&#225;tico (TEPT), logrando resultados comparables a tratamientos m&#225;s intensivos en tiempo, como la exposici&#243;n prolongada y la terapia de procesamiento cognitivo, pero con menores tasas de abandono. Su corta duraci&#243;n, la ausencia de tareas entre sesiones y las altas tasas de adherencia hacen del WET una alternativa prometedora a la terapia tradicional m&#225;s intensiva en tiempo. A pesar de la eficacia establecida de WET en ensayos controlados, sigue habiendo dudas sobre su viabilidad, tolerabilidad y flexibilidad cuando se implementa en entornos ambulatorios psiqui&#225;tricos rutinarios. Este estudio aborda estas lagunas.</p><p><bold>M&#233;todo:</bold> Veinticuatro pacientes, la mayor&#237;a con TEPT de moderado a severo y comorbilidades psiqui&#225;tricas significativas, fueron reclutados de una cl&#237;nica psiqui&#225;trica ambulatoria especializada en TEPT y sometidos a WET durante un per&#237;odo de cinco a seis semanas. La viabilidad se evalu&#243; en t&#233;rminos de adherencia, satisfacci&#243;n del cliente, acontecimientos adversos, eficacia, requisitos de tiempo y flexibilidad. La gravedad de los s&#237;ntomas del TEPT se midi&#243; al inicio del estudio, despu&#233;s del tratamiento y durante el seguimiento de un mes utilizando la lista de chequeo de TEPT para el DSM-5. El tratamiento se administr&#243; mediante sesiones presenciales en la cl&#237;nica (<italic toggle="yes">n</italic>=7) o por videoconferencia (<italic toggle="yes">n</italic>=15), y dos participantes recibieron una combinaci&#243;n de formatos.</p><p><bold>Resultados:</bold> La adherencia fue alta, con 23 de 24 participantes que completaron el tratamiento. La satisfacci&#243;n del cliente fue excelente, con una puntuaci&#243;n media de 25,91 (DE=4,27) en el Cuestionario de Satisfacci&#243;n del Cliente. El tiempo medio requerido por el terapeuta fue inferior a seis horas por paciente. Los an&#225;lisis dentro del grupo mostraron reducciones significativas de los s&#237;ntomas de TEPT en el seguimiento de un mes (<italic toggle="yes">d</italic> = 1,08; IC del 95%: 0,47-1,69). No se notificaron acontecimientos adversos graves. El WET fue factible, eficiente en cuanto a recursos, compatible con v&#237;deo y adecuado para su aplicaci&#243;n por terapeutas individuales con formaci&#243;n limitada.</p><p><bold>Conclusiones:</bold> WET demostr&#243; ser una intervenci&#243;n factible, efectiva y eficiente en recursos para el TEPT en la atenci&#243;n psiqui&#225;trica de rutina. Su implementaci&#243;n puede ampliar el acceso al tratamiento basado en la evidencia y reducir la dependencia de la TCC de dosis completa. La investigaci&#243;n futura debe explorar su papel en la optimizaci&#243;n de las v&#237;as de atenci&#243;n y abordar las listas de espera.</p></trans-abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>Post-traumatic stress disorder</kwd><kwd>complex post-traumatic stress disorder</kwd><kwd>written exposure therapy</kwd><kwd>trauma focused cognitive behaviour therapy</kwd></kwd-group><kwd-group kwd-group-type="author" xml:lang="es"><title>PALABRAS CLAVE</title><kwd>Trastorno de estr&#233;s postraum&#225;tico</kwd><kwd>trastorno de estr&#233;s postraum&#225;tico complejo</kwd><kwd>terapia de exposici&#243;n escrita</kwd><kwd>terapia cognitivo-conductual centrada en el trauma</kwd></kwd-group><counts><fig-count count="0"/><table-count count="4"/><equation-count count="0"/><ref-count count="29"/><page-count count="11"/><word-count count="6686"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" disp-level="1" id="S001"><label>1.</label><title>Introduction</title><p>Posttraumatic stress disorder (PTSD) is one of the most prevalent psychiatric conditions, with a lifetime prevalence of approximately 5.6% (Koenen et al., <xref rid="CIT0014" ref-type="bibr">2017</xref>). Without treatment, PTSD often becomes chronic, imposing significant personal, societal, and economic burdens, including increased mortality risk and comorbidity with other physical and mental health conditions (Kessler et al., <xref rid="CIT0013" ref-type="bibr">1995</xref>; Song et al., <xref rid="CIT0027" ref-type="bibr">2018</xref>; Steinert et al., <xref rid="CIT0028" ref-type="bibr">2015</xref>).</p><p>Several evidence-based psychotherapies are available for PTSD, with prolonged exposure therapy (PE) and cognitive processing therapy (CPT) having the strongest empirical support (Hamblen et al., <xref rid="CIT0012" ref-type="bibr">2019</xref>). These treatments typically consist of 8&#8211;15 sessions, each lasting 60&#8211;90&#8197;min, and include between-session assignments. Many individuals with PTSD face significant barriers to accessing or completing trauma-focused treatments, including time constraints, financial limitations, a shortage of trained therapists, and the emotional burden placed on clinicians (Finch et al., <xref rid="CIT0009" ref-type="bibr">2020</xref>). Dropout rates further complicate the issue, with averages of 22% for PE and 30% for CPT in randomised controlled trials (Lewis, Roberts, Andrew, et al., <xref rid="CIT0016" ref-type="bibr">2020</xref>). Additionally, clinicians who receive training often struggle to implement these therapies due to heavy caseloads or the logistical challenges of delivering time-intensive interventions in certain clinical settings (Maguen et al., <xref rid="CIT0019" ref-type="bibr">2018</xref>). These challenges result in the underutilisation of evidence-based PTSD treatments, leaving many individuals without the care they need.</p><p>Written Exposure Therapy (WET) is emerging as a streamlined, effective, and resource-efficient intervention for PTSD. This structured treatment consists of five sessions, during which patients engage in focused 30-minute writing exercises about a specific traumatic event, making it a brief yet impactful alternative to more resource-intensive therapies. Notably, the therapy does not include any between-session assignments (Sloan &amp; Marx, <xref rid="CIT0022" ref-type="bibr">2019</xref>). By focusing on structured writing about a single traumatic event, it is hypothesised that WET enables the individual to develop new, adaptive responses to trauma reminders. Its shorter format and reduced resource requirements make WET particularly suitable for healthcare systems with limited capacity and for patients constrained by time or resources. The simplicity of the intervention also reduces the likelihood of unforeseen barriers arising during treatment, improving adherence and accessibility (DeJesus et al., <xref rid="CIT0008" ref-type="bibr">2024</xref>).</p><p>To date, three non-inferiority trials have demonstrated that WET is as effective as PE and CPT in reducing PTSD symptoms (Sloan et al., <xref rid="CIT0024" ref-type="bibr">2018</xref>, <xref rid="CIT0025" ref-type="bibr">2022</xref>, <xref rid="CIT0023" ref-type="bibr">2023</xref>). Notably, WET has demonstrated significantly lower dropout rates than PE and CPT, ranging from 6% to 9% across multiple trials (Sloan et al., <xref rid="CIT0024" ref-type="bibr">2018</xref>; Sloan et al., <xref rid="CIT0023" ref-type="bibr">2023</xref>) The shorter duration, minimal demands on both patients and clinicians, and growing evidence base position WET as a compelling alternative to traditional trauma-focused therapies.</p><p>Despite its promise, WET has primarily been evaluated in highly controlled research environments. While these trials support its efficacy, there is limited evidence on whether WET can be feasibly and effectively implemented in routine psychiatric outpatient care. Real-world clinical settings often involve more complex patient presentations, limited time and resources, and varying levels of therapist training &#8211; all of which may influence treatment delivery.</p><p>This study aims to address this gap by evaluating the feasibility of implementing WET in a publicly funded general psychiatric outpatient clinic. We examine practical aspects such as adherence, client satisfaction, adverse events, and preliminary clinical outcomes. By focusing on implementation in routine care, this study may inform broader dissemination strategies and help determine whether WET can serve as a scalable, resource-efficient treatment option for PTSD in everyday psychiatric practice.</p></sec><sec sec-type="methods" disp-level="1" id="S002"><label>2.</label><title>Method</title><sec disp-level="2" id="S002-S2001"><label>2.1.</label><title>Design</title><p>This was a single centre uncontrolled cohort study performed at a publicly funded outpatient psychiatric setting in Stockholm, Sweden. Recruitment started on 27 October 2020 and ended 30 March 2021. Ethical approval was granted by The National Ethical Review Board in Sweden (registration ID: 2019-04414). The trial was registered on ClinicalTrials.gov on 1 April 2020, before any participant was enrolled (registration ID: <ext-link ext-link-type="pmc:clinical-trial" xlink:href="NCT04328935">NCT04328935</ext-link>). All participants provided informed consent.</p></sec><sec disp-level="2" id="S002-S2002"><label>2.2.</label><title>Participants</title><p>The eligibility criteria were designed to recruit a representative sample of PTSD patients receiving outpatient psychiatric care for PTSD at the clinic, aiming to ensure strong external validity. Inclusion criteria required participants to have a primary diagnosis of PTSD, as assessed with the psychiatric interview Mini-International Neuropsychiatric Interview 7.0 (MINI 7.0) (Sheehan et al., <xref rid="CIT0021" ref-type="bibr">1998</xref>). Participants on psychotropic medication were required to have maintained a stable dose for at least four weeks prior to enrolment. Exclusion criteria included ongoing psychotherapy for PTSD, severe psychiatric comorbidities as the primary concern (e.g. substance dependence, untreated bipolar disorder, psychotic symptoms, severe depression, or borderline personality disorder), an immediate risk of suicide requiring urgent intervention, and ongoing trauma-related threats (e.g. residing in a violent environment).</p></sec><sec disp-level="2" id="S002-S2003"><label>2.3.</label><title>Recruitment</title><p>Participants were recruited from a publicly funded open-care psychiatric clinic specialised in PTSD in Stockholm, Sweden. All participants had previously undergone a comprehensive clinical assessment at the clinic, during which PTSD had been established as the primary diagnosis using the MINI 7.0. Patients who expressed interest in the study were invited to a meeting with a psychologist from the research team. At this meeting, they received detailed written and verbal information about the study's objectives, potential benefits and risks, and participation requirements, along with a consent form. After providing written informed consent and confirming eligibility, participants were formally enrolled, and treatment commenced shortly thereafter.</p></sec><sec disp-level="2" id="S002-S2004"><label>2.4.</label><title>Therapists</title><p>The treatment was delivered by three clinical psychologists and one resident psychologist at the recruitment site, all of whom had prior training in PE. In the Swedish educational system, a resident psychologist is a graduate who has completed a five-year Master&#8217;s programme in Clinical Psychology and is undergoing a mandatory one-year supervised clinical training before licensure. The resident involved in this study was in the final stage of this training. The three licensed clinical psychologists had on average, 8 years of post-graduate clinical experience (SD&#8201;=&#8201;1.7). One therapist completed a one-day online workshop specifically focused on WET as part of their preparation.</p></sec><sec disp-level="2" id="S002-S2005"><label>2.5.</label><title>COVID-19 adaptations</title><p>The original study protocol specified that all participants would receive treatment in person at the clinic. However, due to COVID-19-related restrictions, the protocol was adapted to allow remote delivery via a secure, encrypted video platform. Of the 24 participants, six completed all sessions in person, and one participant began in-person treatment but discontinued after the first session. Fifteen participants received all sessions via video conferencing. Two participants received a combination of formats: one had five in-person sessions and one by phone, while the other had one in-person session and four via video. This distribution reflects the flexible implementation necessitated by the pandemic context.</p></sec><sec disp-level="2" id="S002-S2006"><label>2.6.</label><title>Treatment</title><p>WET is a structured trauma-focused intervention consisting of five sessions, with the possibility of adding a sixth session if necessary (Sloan &amp; Marx, <xref rid="CIT0022" ref-type="bibr">2019</xref>). In this study, each session lasted between 40 and 60&#8197;min. The first session included a brief psychoeducation component and explanation of the treatment rationale, consistent with the WET protocol. Participants were instructed to complete a written trauma narrative during each session, focusing on the same traumatic event throughout treatment. Initial sessions involved writing about the trauma event itself, while later sessions expanded to include the impact of the trauma on the participant&#8217;s life. Each writing task lasted 30&#8197;min.</p><p>Adaptations to the WET protocol were made based on updated recommendations from the original authors (personal communication Sloan &amp; Marx, webinar attended 2021-05-21). These adjustments allowed participants to complete their writing assignments either in a consulting room with the therapist present or in a separate room, depending on their preference. In cases where assignments were completed separately, the therapist escorted the participant back to the consulting room at the end of the task. The therapist announced when 30&#8197;min had elapsed and asked participants to conclude their writing. Sessions ended with a brief discussion about the participant&#8217;s experience with the task and their emotional reactions.</p><p>Between sessions, therapists reviewed the written accounts to ensure adherence to the instructions and provided individualised feedback during subsequent sessions to help participants fully engage with the therapeutic process. Psychoeducation materials were distributed during the first session, and written instructions were provided throughout the treatment.</p></sec><sec disp-level="2" id="S002-S2007"><label>2.7.</label><title>Assessment of feasibility</title><p>The evaluation of feasibility was guided by the definition proposed by Bird et al. (<xref rid="CIT0003" ref-type="bibr">2014</xref>) and Bowen et al. (<xref rid="CIT0007" ref-type="bibr">2009</xref>), which describes feasibility as the extent to which an intervention can be successfully delivered within a specific setting, considering practical constraints such as time, resources, and contextual barriers. Specific obstacles related to PTSD treatment, such as patient dropout rates and clinician workload (Finch et al., <xref rid="CIT0009" ref-type="bibr">2020</xref>), were also taken into account. To systematically assess these factors, the Structured Assessment of Feasibility (SAFE) framework (Bird et al., <xref rid="CIT0003" ref-type="bibr">2014</xref>) was utilised, providing a standardised method to evaluate key elements influencing the implementation and scalability of trauma-focused therapy. Treatment adherence was measured by the number of sessions completed and compliance with the intervention protocol during these sessions. Therapists documented whether patients completed written trauma accounts in alignment with the WET protocol for each session. Tolerability was assessed by monitoring treatment dropouts. Client satisfaction was measured using the Client Satisfaction Questionnaire (CSQ-8) (Larsen et al., <xref rid="CIT0015" ref-type="bibr">1979</xref>), which participants completed during the post-treatment assessment. The scoring system, as proposed by (Smith et al., <xref rid="CIT0026" ref-type="bibr">2014</xref>), categorised satisfaction levels as poor (scores of 8&#8211;13), fair (14&#8211;19), good (20&#8211;25), or excellent (26&#8211;32). Adverse events were monitored using the Safety Monitoring Uniform Report Form (Andersson et al., <xref rid="CIT0001" ref-type="bibr">2015</xref>) which was administered at the end of treatment sessions and during follow-up. The form begins with an open-ended question to identify any adverse events or medical side effects experienced during treatment. If participants reported adverse experiences, therapists followed up with additional clarifying questions. The full checklist of potential adverse effects was available as a reference but was not administered in detail unless a participant endorsed any adverse event. This procedure was implemented to reduce participant burden and to reflect the pragmatic conditions of routine clinical care. The final section evaluates hopelessness and suicidal thoughts, focusing on the patient&#8217;s will to live and the perceived likelihood of acting on suicidal ideation. Serious Adverse Events (SAEs) were defined in accordance with international research standards as any event that resulted in death, was life-threatening, required hospitalisation, or led to significant functional impairment.</p><p>The time investment required from staff was assessed, including time allocated for training prior to delivering the intervention, the duration of therapy sessions, and any additional supervision provided during the treatment process. Total therapist time per client was calculated according to the guidelines outlined in the WET manual. Any deviations from these guidelines, such as extended session durations or additional sessions, were carefully documented by the therapists.</p><p>Pilotability, flexibility, and treatment length were evaluated using the Structured Assessment of Feasibility (SAFE) framework (Bird et al., <xref rid="CIT0003" ref-type="bibr">2014</xref>a). Pilotability refers to the feasibility of implementing WET with a single therapist or a small team, rather than requiring extensive staff resources. Flexibility assesses the adaptability of WET to different clinical contexts or patient needs. Finally, the evaluation examined the standard five- to six-session structure of WET to determine whether it could effectively address the varying demands of diverse clinical scenarios.</p></sec><sec disp-level="2" id="S002-S2008"><label>2.8.</label><title>Assessment of clinical outcomes</title><p>All clinical outcome measures were assessed at baseline, post-treatment, and at one-month follow-up.</p><p>Preliminary effectiveness was primarily measured using the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). The PCL-5 measures the 20 PTSD symptoms defined in the DSM-5 over the previous month, using a four-point scale. Total scores range from 0 to 80, with higher scores reflecting greater symptom severity (Blevins et al., <xref rid="CIT0004" ref-type="bibr">2015</xref>). The PCL-5 demonstrates excellent internal consistency (alpha&#8201;=&#8201;0.95) and strong test-retest reliability (Blevins et al., <xref rid="CIT0004" ref-type="bibr">2015</xref>; Bovin et al., <xref rid="CIT0006" ref-type="bibr">2016</xref>) Participants were classified as responders if they showed a reduction of ten or more points on the PCL-5, as worsened if their scores increased with 10 points, and as remitters if their total score fell below 29, the proposed cut-off for probable PTSD (Bondjers, <xref rid="CIT0005" ref-type="bibr">2020</xref>). Currently, there are no empirically established severity ranges for PCL-5 scores. However, a total score of 50 or higher is commonly interpreted as indicative of a higher symptom burden and may reflect severe PTSD symptomatology (Bovin et al., <xref rid="CIT0006" ref-type="bibr">2016</xref>).</p><p>The Montgomery &#197;sberg Depression Rating Scale&#8211;Self-report (MADRS-S) (Svanborg &amp; Asberg, <xref rid="CIT0029" ref-type="bibr">1994</xref>) was used to assess symptoms of depression. The MADRS-S evaluates the severity of depressive symptoms over the past three days through nine items rated on a seven-point scale, with total scores ranging from 0 to 54. Higher scores indicate greater symptom severity.</p><p>The EuroQol five-dimension questionnaire (EQ-5D) was used to evaluate health-related quality of life. It assesses five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three response levels: no problems, some problems, and extreme problems/unable to perform (Balestroni &amp; Bertolotti, <xref rid="CIT0002" ref-type="bibr">2012</xref>). The EQ-5D captures a total of 243 unique health states, and results can be reported either by individual dimensions or as a composite index score (Rabin &amp; de Charro, <xref rid="CIT0020" ref-type="bibr">2001</xref>). In this study, we focused on calculating the composite index score and report the scores from the Visual Analogue Scale (VAS-scale).</p></sec><sec disp-level="2" id="S002-S2009"><label>2.9.</label><title>Statistical analysis</title><p>The statistical analyses were calculated in STATA 16.1. Clinical outcome scales were analysed using a paired t-test baseline to post-treatment and baseline to 1-month follow-up.</p></sec></sec><sec sec-type="results" disp-level="1" id="S003"><label>3.</label><title>Results</title><p>Of the 27 individuals who expressed interest in participating, 24 were enrolled and began Written Exposure Therapy (WET). Three applicants were excluded prior to treatment initiation due to ongoing medical adjustments, clinical decisions to prioritise treatment for severe depression, or the presence of an ongoing trauma-related threat.</p><p><xref rid="T0001" ref-type="table">Table 1</xref> provides an overview of the baseline characteristics of the recruited participants.
<table-wrap position="float" id="T0001" orientation="portrait"><label>Table 1.</label><caption><p>Clinical characteristics and sociodemographic of the sample.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><thead valign="bottom"><tr><th colspan="2" align="center" rowspan="1">Baseline characteristics</th><th align="center" colspan="1" rowspan="1">&#160;</th></tr></thead><tbody><tr><td rowspan="3" align="left" colspan="1">Gender, <italic toggle="yes">n (%)</italic></td><td align="left" colspan="1" rowspan="1">Women</td><td align="char" char="(" colspan="1" rowspan="1">17 (71%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Men</td><td align="char" char="(" colspan="1" rowspan="1">6 (25%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Non-binary</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td rowspan="2" align="left" colspan="1">Age</td><td align="left" colspan="1" rowspan="1">Mean <italic toggle="yes">(SD)</italic></td><td align="char" char="(" colspan="1" rowspan="1">34.04 (11.07)</td></tr><tr><td align="left" colspan="1" rowspan="1">Range</td><td align="center" colspan="1" rowspan="1">19&#8211;68</td></tr><tr><td rowspan="3" align="left" colspan="1">Highest education, <italic toggle="yes">n (%)</italic></td><td align="left" colspan="1" rowspan="1">College/university</td><td align="char" char="(" colspan="1" rowspan="1">13 (54%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Secondary school</td><td align="char" char="(" colspan="1" rowspan="1">5 (21%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Primary school</td><td align="char" char="(" colspan="1" rowspan="1">6 (25%)</td></tr><tr><td rowspan="5" align="left" colspan="1">Occupational status, <italic toggle="yes">n (%)</italic></td><td align="left" colspan="1" rowspan="1">Working</td><td align="char" char="(" colspan="1" rowspan="1">9 (38%)</td></tr><tr><td align="left" colspan="1" rowspan="1">On sick leave</td><td align="char" char="(" colspan="1" rowspan="1">8 (33%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Student</td><td align="char" char="(" colspan="1" rowspan="1">5 (21%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Parental leave</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Unemployed</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td rowspan="4" align="left" colspan="1">Comorbidity</td><td align="left" colspan="1" rowspan="1">&gt;2 additional diagnoses</td><td align="char" char="(" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">2 additional diagnoses</td><td align="char" char="(" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">1 additional diagnosis</td><td align="char" char="(" colspan="1" rowspan="1">9 (38%)</td></tr><tr><td align="left" colspan="1" rowspan="1">No additional diagnosis</td><td align="char" char="(" colspan="1" rowspan="1">9 (38%)</td></tr><tr><td rowspan="5" align="left" colspan="1">Trauma exposure</td><td align="left" colspan="1" rowspan="1">Multiple trauma</td><td align="char" char="(" colspan="1" rowspan="1">23 (96%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Single trauma</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Childhood trauma only</td><td align="char" char="(" colspan="1" rowspan="1">7 (29%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Adulthood trauma only</td><td align="char" char="(" colspan="1" rowspan="1">4 (16%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Childhood and adulthood trauma</td><td align="char" char="(" colspan="1" rowspan="1">13 (53%)</td></tr><tr><td rowspan="3" align="left" colspan="1">Index trauma</td><td align="left" colspan="1" rowspan="1">Sexual assault</td><td align="char" char="(" colspan="1" rowspan="1">13 (54%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Interpersonal violence</td><td align="char" char="(" colspan="1" rowspan="1">7 (29%)</td></tr><tr><td align="left" colspan="1" rowspan="1">Other</td><td align="char" char="(" colspan="1" rowspan="1">4 (16%)</td></tr><tr><td rowspan="4" align="left" colspan="1">PTSD duration</td><td align="left" colspan="1" rowspan="1">&lt; 5 years</td><td align="char" char="(" colspan="1" rowspan="1">2 (8%)</td></tr><tr><td align="left" colspan="1" rowspan="1">5&#8211;10 years</td><td align="char" char="(" colspan="1" rowspan="1">7 (29%)</td></tr><tr><td align="left" colspan="1" rowspan="1">10&#8211;20 years</td><td align="char" char="(" colspan="1" rowspan="1">7 (29%)</td></tr><tr><td align="left" colspan="1" rowspan="1">20- years</td><td align="char" char="(" colspan="1" rowspan="1">8 (33%)</td></tr><tr><td rowspan="2" align="left" colspan="1">Previous TF-CBT</td><td align="left" colspan="1" rowspan="1">Yes</td><td align="char" char="(" colspan="1" rowspan="1">4 (17%)</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="char" char="(" colspan="1" rowspan="1">20 (83%)</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Note: Categories for timing of trauma (childhood, adulthood, both) are not mutually exclusive with the single/multiple trauma classification. Percentages are based on the total sample (<italic toggle="yes">N</italic>&#8201;=&#8201;24). Abbreviations: TF-CBT, trauma-focused cognitive behaviour therapy.</p></fn></table-wrap-foot></table-wrap></p><p>The sample predominantly consisted of women (71%), with a mean age of 34.04 years (SD&#8201;=&#8201;11.07), ranging from 19 to 68 years. Over half of the participants (54%) had a college or university degree, and 33% were on sick leave.</p><p>Nineteen participants (79%) presented with moderate to severe PTSD symptoms according to the PCL-5. Among them, 14 participants (58%) were classified as having severe symptoms (scores &#8805;50), and 5 participants (21%) as having moderate symptoms (scores between 40 and 49). The remaining 5 participants (21%) had mild symptoms, with PCL-5 scores below 40.</p><p>The majority of participants had long-standing PTSD. Only two individuals (8%) reported experiencing symptoms for less than five years. In contrast, seven participants (29%) reported symptom durations of 5&#8211;10 years, another seven (29%) had experienced symptoms for 10&#8211;20 years, and eight participants (33%) reported having lived with PTSD symptoms for more than 20 years.</p><sec disp-level="2" id="S003-S2001"><label>3.1.</label><title>Feasibility and acceptability</title><p>No severe adverse events were reported. However, ten participants (42%) reported a temporary increase in PTSD symptoms during treatment, including intrusive memories, negative thoughts, heightened arousal, and reactivity. These responses are consistent with what is commonly observed in trauma-focused, exposure-based therapy. Rather than indicating harm, such symptom exacerbation is generally understood as a sign of therapeutic engagement with traumatic material and normative emotional processing. One participant also reported a recurrence of suicidal thoughts, though without intent or behaviour; these thoughts subsided later in treatment alongside improvements in PTSD symptoms. All but one participant completed all treatment sessions and writing assignments, resulting in a dropout rate of 4%.</p><p>The mean CSQ-8 score was 25.91 (SD&#8201;=&#8201;4.27). <xref rid="T0002" ref-type="table">Table 2</xref> summarises the mean scores for each item on the CSQ-8, reflecting overall high satisfaction with the intervention. Notably, 91% of participants rated the quality of service as &#8216;excellent&#8217; or &#8216;good,&#8217; and 96% felt they received the kind of service they wanted. Most participants (83%) reported that the service met &#8216;most&#8217; or &#8216;almost all&#8217; of their needs. Furthermore, 91% indicated they would recommend the service to a friend, and 87% expressed being &#8216;mostly&#8217; or &#8216;very satisfied&#8217; with the amount of help received. Importantly, 87% stated the intervention helped them deal &#8216;a great deal&#8217; or &#8216;somewhat&#8217; with their problems, and 83% expressed satisfaction with the service overall. Lastly, 83% indicated they would return to the service if needed in the future.
<table-wrap position="float" id="T0002" orientation="portrait"><label>Table 2.</label><caption><p>Response frequency on each item on the CSQ-8.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><tbody><tr><td colspan="2" align="left" rowspan="1">How would you rate the quality of service you received?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Excellent</td><td align="char" char="(" colspan="1" rowspan="1">11 (48%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Good</td><td align="char" char="(" colspan="1" rowspan="1">10 (43%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Fair</td><td align="char" char="(" colspan="1" rowspan="1">2 (9%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Poor</td><td align="char" char="(" colspan="1" rowspan="1">0 (0%)</td></tr><tr><td colspan="2" align="left" rowspan="1">Did you get the kind of service you wanted?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, definitely not</td><td align="char" char="(" colspan="1" rowspan="1">0 (0%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, not really</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, generally</td><td align="char" char="(" colspan="1" rowspan="1">16 (70%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, definitely</td><td align="char" char="(" colspan="1" rowspan="1">6 (26%)</td></tr><tr><td colspan="2" align="left" rowspan="1">To what extent has our service met your needs?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Almost all of my needs have been met</td><td align="char" char="(" colspan="1" rowspan="1">5 (22%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Most of my needs have been met</td><td align="char" char="(" colspan="1" rowspan="1">14 (61%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Only a few of my needs have been met</td><td align="char" char="(" colspan="1" rowspan="1">3 (13%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;None of my needs have been met</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td colspan="2" align="left" rowspan="1">If a friend were in need of similar help, would you recommend our service to him or her?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, definitely not</td><td align="char" char="(" colspan="1" rowspan="1">0 (0%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, I don&#8217;t think so</td><td align="char" char="(" colspan="1" rowspan="1">2 (9%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, I think so (3)</td><td align="char" char="(" colspan="1" rowspan="1">6 (26%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, definitely</td><td align="char" char="(" colspan="1" rowspan="1">15 (65%)</td></tr><tr><td colspan="2" align="left" rowspan="1">How satisfied are you with the amount of help you received?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Quite dissatisfied</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Indifferent or mildly dissatisfied</td><td align="char" char="(" colspan="1" rowspan="1">2 (9%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Mostly satisfied</td><td align="char" char="(" colspan="1" rowspan="1">13 (57%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Very satisfied</td><td align="char" char="(" colspan="1" rowspan="1">7 (30%)</td></tr><tr><td colspan="2" align="left" rowspan="1">Have the services you received helped you to deal more effectively with your problems?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, they helped a great deal</td><td align="char" char="(" colspan="1" rowspan="1">8 (35%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, they helped somewhat</td><td align="char" char="(" colspan="1" rowspan="1">12 (52%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, they really didn&#8217;t help</td><td align="char" char="(" colspan="1" rowspan="1">2 (9%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, they seemed to make things worse</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td colspan="2" align="left" rowspan="1">In an overall, general sense, how satisfied are you with the service you received?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Very satisfied</td><td align="char" char="(" colspan="1" rowspan="1">10 (43%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Mostly satisfied</td><td align="char" char="(" colspan="1" rowspan="1">9 (39%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Indifferent of mildly dissatisfied</td><td align="char" char="(" colspan="1" rowspan="1">2 (9%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Quite dissatisfied</td><td align="char" char="(" colspan="1" rowspan="1">2 (9%)</td></tr><tr><td colspan="2" align="left" rowspan="1">If you were to seek help again, would you come back to our service?</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, definitely not</td><td align="char" char="(" colspan="1" rowspan="1">1 (4%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No, I don&#8217;t think so</td><td align="char" char="(" colspan="1" rowspan="1">3 (13%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, I think so</td><td align="char" char="(" colspan="1" rowspan="1">8 (35%)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes, definitely</td><td align="char" char="(" colspan="1" rowspan="1">11 (48%)</td></tr></tbody></table></table-wrap></p><sec disp-level="3" id="S003-S2001-S3001"><label>3.1.1.</label><title>Time requirement</title><p>In accordance with the manual the therapists learned how to conduct WET by reading the manual (Sloan &amp; Marx, <xref rid="CIT0022" ref-type="bibr">2019</xref>) and did not receive any supervision. It is recommended, but not a requirement, to attend a one-day webinar or workshop, which one of the licensed psychologists did. One-hour sessions were in general sufficient for the therapist within which to prepare the patient, give treatment as well as documentation, and read the written accounts, with an additional 15 min for the first session. The mean number of sessions were 5.2, which means approximately 6 h of time required for each patient.</p></sec><sec disp-level="3" id="S003-S2001-S3002"><label>3.1.2.</label><title>Pilotability</title><p>WET was implemented by regular clinical staff without requiring additional resources beyond those typically available in the clinic. The upfront costs were minimal, limited to purchasing the treatment manual (list price $39.99) and optional training fees.</p></sec><sec disp-level="3" id="S003-S2001-S3003"><label>3.1.3.</label><title>Flexibility and length of treatment</title><p>In this study we used the possibility of adding a sixth session when ratings of discomfort did not decrease or if the patient did not write about essential parts of the traumatic event during the first session, which added some flexibility to meet the patients&#8217; needs. The decision whether to offer a sixth session was made by the treating psychologist. In total, nine participants (38%) received a sixth session. The possibility to conduct WET via video-meetings made it possible to adjust to the context of the ongoing covid-19 pandemic. At the outset of the study, no secure technical solution was available for patients to submit their written narratives without compromising confidentiality. As a result, for some participants (n&#8201;=&#8201;4), therapists read the patients&#8217; written assignments aloud during the video sessions. Later in the study, a secure and confidential system was implemented, allowing patients to submit images of their written accounts electronically.</p></sec></sec><sec disp-level="2" id="S003-S2002"><label>3.2.</label><title>Preliminary effectiveness</title><p><xref rid="T0003" ref-type="table">Tables 3</xref> and <xref rid="T0004" ref-type="table">4</xref> summarises the changes in PTSD symptom severity, depressive symptoms, and quality of life.
<table-wrap position="float" id="T0003" orientation="portrait"><label>Table 3.</label><caption><p>Mean scores and outcome statistics for the full sample.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">Mean</th><th align="center" colspan="1" rowspan="1">SD</th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">t</italic></th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">d</italic> (95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">PCL-5</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">51.08</td><td align="char" char="." colspan="1" rowspan="1">12.04</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">37.04</td><td align="char" char="." colspan="1" rowspan="1">19.91</td><td align="char" char="." colspan="1" rowspan="1">3.97</td><td align="char" char="." colspan="1" rowspan="1">&lt;.001</td><td align="char" char="(" colspan="1" rowspan="1">0.86 (0.25&#8211;1.45)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">33.33</td><td align="char" char="." colspan="1" rowspan="1">19.80</td><td align="char" char="." colspan="1" rowspan="1">5.43</td><td align="char" char="." colspan="1" rowspan="1">&lt;.001</td><td align="char" char="(" colspan="1" rowspan="1">1.08 (0.47&#8211;1.69)</td></tr><tr><td align="left" colspan="1" rowspan="1">MADRS-S</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">27.50</td><td align="char" char="." colspan="1" rowspan="1">10.14</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">23.32</td><td align="char" char="." colspan="1" rowspan="1">11.12</td><td align="char" char="." colspan="1" rowspan="1">3.50</td><td align="char" char="." colspan="1" rowspan="1">&lt;.01</td><td align="char" char="(" colspan="1" rowspan="1">0.39 (&#8722;0.19&#8211;0.98)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">21.29</td><td align="char" char="." colspan="1" rowspan="1">11.14</td><td align="char" char="." colspan="1" rowspan="1">5.16</td><td align="char" char="." colspan="1" rowspan="1">&lt;.001</td><td align="char" char="(" colspan="1" rowspan="1">0.58 (0.01&#8211;1.16)</td></tr><tr><td align="left" colspan="1" rowspan="1">EQ-5D index</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">0.61</td><td align="char" char="." colspan="1" rowspan="1">0.23</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">0.65</td><td align="char" char="." colspan="1" rowspan="1">0.20</td><td align="char" char="." colspan="1" rowspan="1">1.28</td><td align="char" char="." colspan="1" rowspan="1">.21</td><td align="char" char="(" colspan="1" rowspan="1">0.20 (&#8722;0.38&#8211;0.78)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">0.67</td><td align="char" char="." colspan="1" rowspan="1">0.19</td><td align="char" char="." colspan="1" rowspan="1">1.81</td><td align="char" char="." colspan="1" rowspan="1">.08</td><td align="char" char="(" colspan="1" rowspan="1">0.32 (&#8722;0.25&#8211;0.89)</td></tr><tr><td align="left" colspan="1" rowspan="1">EQ-5D VAS</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">44.46</td><td align="char" char="." colspan="1" rowspan="1">17.65</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">56.59</td><td align="char" char="." colspan="1" rowspan="1">17.78</td><td align="char" char="." colspan="1" rowspan="1">4.33</td><td align="char" char="." colspan="1" rowspan="1">&lt;.001</td><td align="char" char="(" colspan="1" rowspan="1">0.68 (0.09&#8211;1.28)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">55.17</td><td align="char" char="." colspan="1" rowspan="1">18.12</td><td align="char" char="." colspan="1" rowspan="1">3.40</td><td align="char" char="." colspan="1" rowspan="1">&lt;.01</td><td align="char" char="(" colspan="1" rowspan="1">0.60 (0.02&#8211;1.17)</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>Abbreviations: PCL-5, PTSD Checklist for DSM-5; MADRS-S, Montgomery &#197;sberg Depression Rating Scale &#8211; Self-rated version; EQ-5D, EuroQol-5 Dimension.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="float" id="T0004" orientation="portrait"><label>Table 4.</label><caption><p>Mean scores and outcome statistics for the two treatment formats.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/><col width="1*" span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th colspan="5" align="center" rowspan="1">Face-to-face sessions at the clinic</th><th colspan="5" align="center" rowspan="1">Sessions via video-meeting</th></tr><tr><th align="left" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">Mean</th><th align="center" colspan="1" rowspan="1">SD</th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">t</italic></th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">d</italic> (95% CI)</th><th align="center" colspan="1" rowspan="1">Mean</th><th align="center" colspan="1" rowspan="1">SD</th><th align="center" colspan="1" rowspan="1">T</th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">p</italic></th><th align="center" colspan="1" rowspan="1"><italic toggle="yes">d</italic> (95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">PCL-5</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">52.00</td><td align="char" char="." colspan="1" rowspan="1">14.76</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">50.63</td><td align="char" char="." colspan="1" rowspan="1">10.96</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">45.00</td><td align="char" char="." colspan="1" rowspan="1">20.87</td><td align="char" char="." colspan="1" rowspan="1">1.41</td><td align="char" char="." colspan="1" rowspan="1">.20</td><td align="char" char="(" colspan="1" rowspan="1">0.39 (&#8722;0.61-1.37)</td><td align="char" char="." colspan="1" rowspan="1">32.80</td><td align="char" char="." colspan="1" rowspan="1">18.70</td><td align="char" char="." colspan="1" rowspan="1">3.91</td><td align="char" char="." colspan="1" rowspan="1">&lt;.01</td><td align="char" char="(" colspan="1" rowspan="1">1.17 (0.40&#8211;1.93)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">34.50</td><td align="char" char="." colspan="1" rowspan="1">19.87</td><td align="char" char="." colspan="1" rowspan="1">5.21</td><td align="char" char="." colspan="1" rowspan="1">&lt;.01</td><td align="char" char="(" colspan="1" rowspan="1">1.00 (&#8722;0.06-2.03)</td><td align="char" char="." colspan="1" rowspan="1">32.75</td><td align="char" char="." colspan="1" rowspan="1">20.38</td><td align="char" char="." colspan="1" rowspan="1">3.82</td><td align="char" char="." colspan="1" rowspan="1">&lt;.01</td><td align="char" char="(" colspan="1" rowspan="1">1.09 (0.34&#8211;1.83)</td></tr><tr><td align="left" colspan="1" rowspan="1">MADRS-S</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">28.00</td><td align="char" char="." colspan="1" rowspan="1">10.47</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">27.25</td><td align="char" char="." colspan="1" rowspan="1">10.31</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">23.88</td><td align="char" char="." colspan="1" rowspan="1">9.91</td><td align="char" char="." colspan="1" rowspan="1">2.78</td><td align="char" char="." colspan="1" rowspan="1">&lt;.05</td><td align="char" char="(" colspan="1" rowspan="1">0.40 (&#8722;0.59-1.39)</td><td align="char" char="." colspan="1" rowspan="1">23.00</td><td align="char" char="." colspan="1" rowspan="1">12.11</td><td align="char" char="." colspan="1" rowspan="1">2.58</td><td align="char" char="." colspan="1" rowspan="1">&lt;.05</td><td align="char" char="(" colspan="1" rowspan="1">0.38 (&#8722;0.35&#8211;1.10)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">21.00</td><td align="char" char="." colspan="1" rowspan="1">11.08</td><td align="char" char="." colspan="1" rowspan="1">5.52</td><td align="char" char="." colspan="1" rowspan="1">&lt;.001</td><td align="char" char="(" colspan="1" rowspan="1">0.65 (&#8722;0.37-1.65)</td><td align="char" char="." colspan="1" rowspan="1">21.44</td><td align="char" char="." colspan="1" rowspan="1">11.52</td><td align="char" char="." colspan="1" rowspan="1">3.40</td><td align="char" char="." colspan="1" rowspan="1">&lt;.01</td><td align="char" char="(" colspan="1" rowspan="1">0.53 (&#8722;0.18-1.23)</td></tr><tr><td align="left" colspan="1" rowspan="1">EQ-5D index</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">0.55</td><td align="char" char="." colspan="1" rowspan="1">0.26</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">0.64</td><td align="char" char="." colspan="1" rowspan="1">0.21</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">0.58</td><td align="char" char="." colspan="1" rowspan="1">0.21</td><td align="char" char="." colspan="1" rowspan="1">0.49</td><td align="char" char="." colspan="1" rowspan="1">0.64</td><td align="char" char="(" colspan="1" rowspan="1">0.12 (&#8722;0.86-1.10)</td><td align="char" char="." colspan="1" rowspan="1">0.69</td><td align="char" char="." colspan="1" rowspan="1">0.19</td><td align="char" char="." colspan="1" rowspan="1">1.17</td><td align="char" char="." colspan="1" rowspan="1">0.26</td><td align="char" char="(" colspan="1" rowspan="1">0.28 (&#8722;0.45&#8211;1.00)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">0.62</td><td align="char" char="." colspan="1" rowspan="1">0.21</td><td align="char" char="." colspan="1" rowspan="1">1.23</td><td align="char" char="." colspan="1" rowspan="1">0.26</td><td align="char" char="(" colspan="1" rowspan="1">0.56 (&#8722;0.31-1.43)</td><td align="char" char="." colspan="1" rowspan="1">0.70</td><td align="char" char="." colspan="1" rowspan="1">0.18</td><td align="char" char="." colspan="1" rowspan="1">1.35</td><td align="char" char="." colspan="1" rowspan="1">0.20</td><td align="char" char="(" colspan="1" rowspan="1">0.27 (&#8722;0.11&#8211;0.65)</td></tr><tr><td align="left" colspan="1" rowspan="1">EQ-5D VAS</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Pre</td><td align="char" char="." colspan="1" rowspan="1">45.50</td><td align="char" char="." colspan="1" rowspan="1">19.13</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">43.94</td><td align="char" char="." colspan="1" rowspan="1">17.49</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="(" colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">Post</td><td align="char" char="." colspan="1" rowspan="1">60.25</td><td align="char" char="." colspan="1" rowspan="1">13.60</td><td align="char" char="." colspan="1" rowspan="1">2.47</td><td align="char" char="." colspan="1" rowspan="1">&lt;.05</td><td align="char" char="(" colspan="1" rowspan="1">0.89 (&#8722;0.16-1.91)</td><td align="char" char="." colspan="1" rowspan="1">54.50</td><td align="char" char="." colspan="1" rowspan="1">19.95</td><td align="char" char="." colspan="1" rowspan="1">3.50</td><td align="char" char="." colspan="1" rowspan="1">&lt;.01</td><td align="char" char="(" colspan="1" rowspan="1">0.57 (&#8722;0.17&#8211;1.29)</td></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up</td><td align="char" char="." colspan="1" rowspan="1">53.63</td><td align="char" char="." colspan="1" rowspan="1">17.85</td><td align="char" char="." colspan="1" rowspan="1">3.02</td><td align="char" char="." colspan="1" rowspan="1">&lt;.05</td><td align="char" char="(" colspan="1" rowspan="1">0.44 (&#8722;0.56-1.42)</td><td align="char" char="." colspan="1" rowspan="1">55.94</td><td align="char" char="." colspan="1" rowspan="1">18.79</td><td align="char" char="." colspan="1" rowspan="1">2.63</td><td align="char" char="." colspan="1" rowspan="1">&lt;.05</td><td align="char" char="(" colspan="1" rowspan="1">0.66 (&#8722;0.06&#8211;1.37)</td></tr></tbody></table><table-wrap-foot><fn id="TF4"><p>Abbreviations: PCL-5, PTSD Checklist for DSM-5; MADRS-S, Montgomery &#197;sberg Depression Rating Scale &#8211; Self-rated version; EQ-5D, EuroQol-5 Dimension.</p></fn></table-wrap-foot></table-wrap></p><p>The mean PCL-5 scores decreased significantly from 51.08 (SD&#8201;=&#8201;12.04) at pre-treatment to 37.04 (SD&#8201;=&#8201;19.91) post-treatment and further to 33.33 (SD&#8201;=&#8201;19.80) at follow-up. This represents a mean reduction of 17.75 points (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001) from pre-treatment to follow-up, with large effect sizes observed post-treatment (Cohen's <italic toggle="yes">d</italic>&#8201;=&#8201;0.86, 95% CI: 0.25&#8211;1.45) and at follow-up (Cohen's <italic toggle="yes">d</italic>&#8201;=&#8201;1.08, 95% CI: 0.47&#8211;1.69).</p><p>Thirteen participants (54%) achieved a reduction of at least 10 points on the PCL-5 and were classified as responders at post-treatment. This increased to 14 participants (58%) by the one-month follow-up. Additionally, nine participants (38%) at post-treatment and 12 participants (50%) at the one-month follow-up had PCL-5 scores below 30, indicating remitter status.</p><p>MADRS-S scores also demonstrated significant reductions, decreasing from 27.50 (SD&#8201;=&#8201;10.14) at pre-treatment to 23.32 (SD&#8201;=&#8201;11.12) post-treatment and to 21.29 (SD&#8201;=&#8201;11.14) at follow-up. The reduction from pre-treatment to follow-up was statistically significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001) with a moderate effect size (<italic toggle="yes">d</italic>&#8201;=&#8201;0.58, 95% CI: 0.01&#8211;1.16).</p><p>For quality of life measured by EQ-5D, improvements were observed but did not reach statistical significance. The EQ-5D index mean scores increased from 0.61 (SD&#8201;=&#8201;0.23) pre-treatment to 0.65 (SD&#8201;=&#8201;0.20) post-treatment and 0.67 (SD&#8201;=&#8201;0.19) at follow-up. The EQ-5D VAS scores showed a significant increase from 44.46 (SD&#8201;=&#8201;17.65) pre-treatment to 56.59 (SD&#8201;=&#8201;17.78) post-treatment (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, Cohen's <italic toggle="yes">d</italic>&#8201;=&#8201;0.68, 95% CI: 0.09&#8211;1.28), with a slight decrease to 55.17 (SD&#8201;=&#8201;18.12) at follow-up (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.01, <italic toggle="yes">d</italic>&#8201;=&#8201;0.60, 95% CI: 0.02&#8211;1.17).</p><p>When comparing treatment formats, both face-to-face and video-based sessions resulted in significant improvements in PTSD and depressive symptoms. For face-to-face sessions, the mean PCL-5 score decreased from 52.00 (SD&#8201;=&#8201;14.76) to 34.50 (SD&#8201;=&#8201;19.87) at follow-up (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.01, <italic toggle="yes">d</italic>&#8201;=&#8201;1.00). Similarly, video sessions resulted in a reduction from 50.63 (SD&#8201;=&#8201;10.96) to 32.75 (SD &#8201;=&#8201;20.38) (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.01, <italic toggle="yes">d</italic>&#8201;=&#8201;1.09). MADRS-S scores also declined significantly in both formats, with reductions from 28.00 (SD&#8201;=&#8201;10.47) to 21.00 (SD&#8201;=&#8201;11.08) in face-to-face sessions (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, Cohen's <italic toggle="yes">d</italic>&#8201;=&#8201;0.65) and from 27.25 (SD&#8201;=&#8201;10.31) to 21.44 (SD&#8201;=&#8201;11.52) in video sessions (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.01, Cohen's <italic toggle="yes">d</italic>&#8201;=&#8201;0.53). Both formats showed similar effectiveness, supporting WET's flexibility and feasibility in different delivery settings.</p></sec></sec><sec sec-type="discussion" disp-level="1" id="S004"><label>4.</label><title>Discussion</title><p>This is the first study to investigate the feasibility of implementing WET in a regular psychiatric outpatient setting. The findings suggest that WET is feasible, acceptable, and preliminarily effective when delivered by clinical staff with no prior experience in WET-specific protocols. Treatment engagement was high, with all but one participant completing the full intervention, and adherence to the structured writing assignments was excellent. The resources required for implementation were minimal, making WET a practical option for routine psychiatric care.</p><p>The dropout rate in this study (4%) was notably lower compared to the higher rates commonly observed in PE and CPT (Lewis, Roberts, Gibson, et al., <xref rid="CIT0017" ref-type="bibr">2020</xref>). It was also consistent with or even lower than dropout rates reported in previous WET studies, which have demonstrated significantly better treatment retention compared to PE and CPT (DeJesus et al., <xref rid="CIT0008" ref-type="bibr">2024</xref>). The sole dropout occurred early in the treatment process due to the participant experiencing dissociation during the written assignments in WET. The absence of serious adverse effects further supports the acceptability of WET. While half of the participants reported temporary symptom exacerbation during treatment, this aligns with expectations for exposure-based therapies and did not appear to impact overall treatment outcomes. No adverse events were reported by the participant who dropped out of treatment, suggesting that discontinuing WET does not appear to result in harmful or unwanted effects.</p><p>The treatment duration was less than half that of other manualized PTSD treatments, such as PE, CPT, and Eye Movement Desensitisation and Reprocessing therapy (Foa et al., <xref rid="CIT0011" ref-type="bibr">2019</xref>). This shorter duration makes WET a more practical and accessible option for both clinicians and patients during treatment planning. Additionally, WET requires significantly less staff training compared to these alternatives. The study demonstrated that WET can be effectively implemented in a highly specialised PTSD care setting by a small team managing a limited number of participants, without causing disruptions to other staff or clinical services. Its successful integration into this environment highlights its practicality and scalability.</p><p>Based on the SAFE framework (Bird et al., <xref rid="CIT0003" ref-type="bibr">2014</xref>a) WET can be considered a partially flexible intervention. Although the core components are highly structured &#8211; consisting of five manualized sessions with standardised writing tasks &#8211; there is allowance for limited clinical adaptations. In this study, therapists could add a sixth session when clinically indicated and deliver the intervention either in person or via secure video conferencing. Importantly, the treatment was successfully delivered to the majority of participants (63%) entirely via video format, with no indication of lower adherence or poorer outcomes in this group. This finding underscores WET's suitability for remote implementation, which is particularly valuable in contexts with limited access to in-person care or during disruptions such as the COVID-19 pandemic. The flexibility in delivery format, while maintaining fidelity to the core treatment structure, supports WET&#8217;s potential for broader dissemination and integration into routine psychiatric services.</p><p>The large reductions in PTSD and depressive symptoms observed in this study, while lower than those typically reported for first line treatment in clinical trials (Lewis, Roberts, Andrew, et al., <xref rid="CIT0016" ref-type="bibr">2020</xref>), are comparable to the outcomes achieved in real-world clinical settings (Maguen et al., <xref rid="CIT0018" ref-type="bibr">2023</xref>). Interestingly, reductions in PTSD and depressive symptoms continued between post-treatment and the one-month follow-up. This pattern suggests that emotional processing may have extended beyond the final session, consistent with theoretical models of exposure-based treatments (Foa &amp; Kozak, <xref rid="CIT0010" ref-type="bibr">1986</xref>). WET targets avoidance of trauma-related thoughts, feelings, and memories, which allows individuals to engage with previously avoided material. As avoidance diminishes, opportunities arise for new, more adaptive associations to form. These changes may unfold gradually and continue even after the structured treatment has ended. Similar post-treatment improvement trajectories have been observed in other trauma-focused interventions and may reflect consolidation of treatment gains over time. These findings position WET as a less demanding yet equally effective alternative, challenging the traditional belief that intensive daily tasks, such as listening to recordings of imaginal exposure as required in prolonged exposure therapy, are essential for PTSD recovery.</p><p>While the statistical effect sizes for PTSD and depressive symptoms were large, clinical significance is equally important when evaluating treatment utility. At post-treatment, 54% were classified as responders and 38% met remission criteria; these proportions increased to 58% and 50%, respectively, at one-month follow-up. These outcomes suggest that WET may offer substantial clinical benefit for patients in routine psychiatric care. Importantly, our findings align with results from larger real-world implementation studies, such as Maguen et al. (<xref rid="CIT0018" ref-type="bibr">2023</xref>), where WET led to comparable levels of symptom improvement. This consistency across settings underscores the potential for broader clinical application of WET, although larger studies are needed to confirm these preliminary findings.</p><p>Further research could focus on the therapist&#8217;s perspective, since emotional burden of trauma work has been found to be a major barrier in implementing evidence-based treatment for PTSD (Finch et al., <xref rid="CIT0009" ref-type="bibr">2020</xref>). Therapists spend less time directly engaging with trauma accounts, which are submitted in writing and reviewed privately. This approach may help mitigate burnout, a common challenge in implementing evidence-based PTSD treatments (Finch et al., <xref rid="CIT0009" ref-type="bibr">2020</xref>). Future research should explore therapist experiences with WET to better understand its impact on clinician well-being and scalability.</p><p>Clinical guidelines recommend several evidence-based treatments for PTSD, but factors like accessibility, acceptability, and resource availability must guide the choice of intervention. WET&#8217;s streamlined protocol, requiring only 5&#8211;6 brief sessions with no between-session homework, makes it an appealing standalone treatment for many patients. It is particularly suitable for individuals facing logistical or emotional barriers to longer therapies. For patients with residual symptoms, supplementary interventions, such as additional WET sessions or other evidence-based treatments, can be tailored to address specific needs like avoidance or persistent negative cognitions.</p><p>The flexibility of WET was demonstrated in this study by its successful adaptation for remote delivery: 15 participants completed the treatment entirely via secure video sessions, and 2 additional participants received a mix of in-person and remote sessions, resulting in a total of 17 individuals (71%) treated outside the traditional in-person format during the COVID-19 pandemic. Although the small sample size limits conclusions about its effectiveness in this modality, this adaptation suggests that WET could be a valuable option for patients unable or unwilling to attend in-person therapy. Future studies should further investigate the feasibility, safety, and long-term outcomes of delivering WET remotely, as this could significantly enhance its accessibility.</p><p>This study has several strengths. It was conducted in a standard psychiatric outpatient unit, representing the primary level of care for individuals with PTSD, thereby enhancing its ecological validity. Recruitment was broadly inclusive, with minimal exclusion criteria, ensuring a diverse and representative sample. The high prevalence of multiple psychiatric diagnoses among participants reflects the reality of comorbidity in PTSD populations. Furthermore, all participants had experienced multiple traumas, including childhood trauma, demonstrating that WET can be implemented even for patients with severe and complex trauma histories. The systematic collection of adverse event data at every session and during follow-up improved the likelihood of identifying potential treatment-related adverse events.</p><p>The study also has several limitations. The small sample size and lack of a control group reduce the ability to generalise the findings and prevent drawing causal conclusions. However, given that the vast majority of participants (92%) had experienced PTSD symptoms for more than five years prior to treatment, it is unlikely that the observed improvements were due to spontaneous remission or short-term fluctuations. A further limitation is the reliance on the MINI diagnostic interview rather than the gold-standard CAPS-5 for assessing PTSD diagnosis. While the MINI 7.0 is a validated tool, the use of CAPS-5 would have further strengthened diagnostic accuracy. Additionally, the study employed a relatively short follow-up period of one-month post-treatment, limiting conclusions about the long-term effects of WET. Future studies with larger samples, control groups, gold-standard diagnostic tools, and extended follow-up periods are needed to validate and expand these findings. Another limitation is that WET relies on written narrative exposure, which may render the intervention less suitable for individuals with low literacy or limited writing ability. This could restrict its applicability in certain populations, such as those with neurocognitive difficulties, language barriers, or low educational attainment. Given the limited sample size, we did not conduct formal subgroup analyses to examine whether treatment response or satisfaction varied by baseline symptom severity or other individual characteristics. However, this remains an important question for future studies with larger samples, as understanding which patients benefit most &#8211; or least &#8211; from WET may help guide more tailored implementation strategies in routine care. Although we cannot draw firm conclusions, descriptive patterns from the current study provide some preliminary insights. For example, participants who received WET via secure video sessions did not appear to experience lower adherence or less symptom reduction compared to those who received in-person treatment. In fact, the only participant who discontinued treatment had been assigned to the in-person format.</p><p>WET was found to be a viable treatment option for psychiatric patients with PTSD and could be effectively implemented in a psychiatric clinical setting. As a less time-intensive alternative to other evidence-based treatments at the recruiting site, WET demonstrated feasibility and preliminary effectiveness, making it a valuable addition to the range of PTSD interventions. By addressing patient preferences, WET has the potential to enhance access to evidence-based care. The study also highlighted the promising possibility of delivering WET via video, which could further improve accessibility and flexibility in clinical practice. A potential direction for future research could involve conducting a randomised controlled trial to investigate whether the addition of WET as an interim intervention during waiting periods reduces subsequent treatment needs and/or decreases the required dosage of follow-up therapy. Such a study would enable a health-economic analysis to evaluate whether the initial investment in WET yields long-term cost savings by optimising resource allocation and improving treatment efficiency. This approach could provide critical insights into the value of integrating WET into standard care pathways for PTSD</p></sec></body><back><sec sec-type="COI-statement" disp-level="1" id="S005"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec disp-level="1" id="S006"><title>Ethical standards</title><p>The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.</p></sec><sec sec-type="data-availability" disp-level="1" id="S007"><title>Data availability statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors upon request given that the request comply with Swedish and EU laws regulating protection of identifiable data.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Andersson</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Hedman</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Enander</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Radu Djurfeldt</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Ljotsson</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Cervenka</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Isung</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Svanborg</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Mataix-Cols</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Kaldo</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Andersson</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Lindefors</surname>, <given-names>N.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Ruck</surname>, <given-names>C.</given-names></string-name></person-group> (<year>2015</year>). <article-title>D-Cycloserine vs placebo as adjunct to cognitive behavioral therapy for obsessive-compulsive disorder and interaction with antidepressants: A randomized clinical trial</article-title>. <source><italic toggle="yes">JAMA Psychiatry</italic></source>, <volume><italic toggle="yes">72</italic></volume>(<issue>7</issue>), <fpage>659</fpage>&#8211;<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.0546</pub-id><pub-id pub-id-type="pmid">25970252</pub-id></mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Balestroni</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Bertolotti</surname>, <given-names>G.</given-names></string-name></person-group> (<year>2012</year>). <article-title>EuroQol-5D (EQ-5D): an instrument for measuring quality of life</article-title>. <source><italic toggle="yes">Monaldi Archives for Chest Disease</italic></source>, <volume><italic toggle="yes">78</italic></volume>(<issue>3</issue>), <fpage>155</fpage>&#8211;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.4081/monaldi.2012.121</pub-id>. (L'EuroQol-5D (EQ-5D): uno strumento per la misura della qualit&#224; della vita.).<pub-id pub-id-type="pmid">23614330</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bird</surname>, <given-names>V. J.</given-names></string-name>, <string-name name-style="western"><surname>Le Boutillier</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Leamy</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Bradstreet</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Slade</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Evaluating the feasibility of complex interventions in mental health services: Standardised measure and reporting guidelines</article-title>. <source><italic toggle="yes">The British Journal of Psychiatry</italic></source>, <volume><italic toggle="yes">204</italic></volume>(<issue>4</issue>), <fpage>316</fpage>&#8211;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.bp.113.128314</pub-id><pub-id pub-id-type="pmid">24311549</pub-id></mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Blevins</surname>, <given-names>C. A.</given-names></string-name>, <string-name name-style="western"><surname>Weathers</surname>, <given-names>F. W.</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname>, <given-names>M. T.</given-names></string-name>, <string-name name-style="western"><surname>Witte</surname>, <given-names>T. K.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Domino</surname>, <given-names>J. L.</given-names></string-name></person-group> (<year>2015</year>). <article-title>The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation</article-title>. <source><italic toggle="yes">Journal of Traumatic Stress</italic></source>, <volume><italic toggle="yes">28</italic></volume>(<issue>6</issue>), <fpage>489</fpage>&#8211;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1002/jts.22059</pub-id><pub-id pub-id-type="pmid">26606250</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Bondjers</surname>, <given-names>K.</given-names></string-name></person-group> (<year>2020</year>). <source><italic toggle="yes">Post-traumatic stress disorder&#8211;assessment of current diagnostic definitions</italic></source>. <publisher-name>Acta Universitatis Upsaliensis]</publisher-name>.</mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bovin</surname>, <given-names>M. J.</given-names></string-name>, <string-name name-style="western"><surname>Marx</surname>, <given-names>B. P.</given-names></string-name>, <string-name name-style="western"><surname>Weathers</surname>, <given-names>F. W.</given-names></string-name>, <string-name name-style="western"><surname>Gallagher</surname>, <given-names>M. W.</given-names></string-name>, <string-name name-style="western"><surname>Rodriguez</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Schnurr</surname>, <given-names>P. P.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Keane</surname>, <given-names>T. M.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Psychometric properties of the PTSD checklist for diagnostic and statistical manual of mental disorders&#8211;fifth edition (PCL-5) in veterans</article-title>. <source><italic toggle="yes">Psychological Assessment</italic></source>, <volume><italic toggle="yes">28</italic></volume>(<issue>11</issue>), <fpage>1379</fpage>&#8211;<lpage>1391</lpage>. <pub-id pub-id-type="doi">10.1037/pas0000254</pub-id><pub-id pub-id-type="pmid">26653052</pub-id></mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bowen</surname>, <given-names>D. J.</given-names></string-name>, <string-name name-style="western"><surname>Kreuter</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Spring</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Cofta-Woerpel</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Linnan</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Weiner</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Bakken</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Kaplan</surname>, <given-names>C. P.</given-names></string-name>, <string-name name-style="western"><surname>Squiers</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Fabrizio</surname>, <given-names>C.</given-names></string-name></person-group> (<year>2009</year>). <article-title>How we design feasibility studies</article-title>. <source><italic toggle="yes">American Journal of Preventive Medicine</italic></source>, <volume><italic toggle="yes">36</italic></volume>(<issue>5</issue>), <fpage>452</fpage>&#8211;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1016/j.amepre.2009.02.002</pub-id><pub-id pub-id-type="pmid">19362699</pub-id><pub-id pub-id-type="pmcid">PMC2859314</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>DeJesus</surname>, <given-names>C. R.</given-names></string-name>, <string-name name-style="western"><surname>Trendel</surname>, <given-names>S. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Sloan</surname>, <given-names>D. M.</given-names></string-name></person-group> (<year>2024</year>). <article-title>A systematic review of written exposure therapy for the treatment of posttraumatic stress symptoms</article-title>. <source><italic toggle="yes">Psychological Trauma: Theory, Research, Practice, and Policy</italic></source>, <italic toggle="yes">16</italic>(Suppl 3), S620&#8211;S626. <pub-id pub-id-type="doi">10.1037/tra0001659</pub-id>.<pub-id pub-id-type="pmcid">PMC11324852</pub-id><pub-id pub-id-type="pmid">38358724</pub-id></mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Finch</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Ford</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Grainger</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Meiser-Stedman</surname>, <given-names>R.</given-names></string-name></person-group> (<year>2020</year>). <article-title>A systematic review of the clinician related barriers and facilitators to the use of evidence-informed interventions for post traumatic stress</article-title>. <source><italic toggle="yes">Journal of Affective Disorders</italic></source>, <volume><italic toggle="yes">263</italic></volume>, <fpage>175</fpage>&#8211;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2019.11.143</pub-id><pub-id pub-id-type="pmid">31818775</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Foa</surname>, <given-names>E. B.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Kozak</surname>, <given-names>M. J.</given-names></string-name></person-group> (<year>1986</year>). <article-title>Emotional processing of fear: Exposure to corrective information</article-title>. <source><italic toggle="yes">Psychological Bulletin</italic></source>, <volume><italic toggle="yes">99</italic></volume>(<issue>1</issue>), <fpage>20</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1037/0033-2909.99.1.20</pub-id><pub-id pub-id-type="pmid">2871574</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Foa</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Hembree</surname>, <given-names>E. A.</given-names></string-name>, <string-name name-style="western"><surname>Rauch</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Rothbaum</surname>, <given-names>B. O.</given-names></string-name></person-group> (<year>2019</year>). <source><italic toggle="yes">Prolonged exposure therapy for PTSD: Emotional processing of traumatic experiences - therapist guide</italic></source>. <publisher-name>Oxford University Press</publisher-name>. Incorporated. <ext-link xlink:href="https://books.google.se/books?id=eUKjDwAAQBAJ" ext-link-type="uri">https://books.google.se/books?id=eUKjDwAAQBAJ</ext-link>.</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Hamblen</surname>, <given-names>J. L.</given-names></string-name>, <string-name name-style="western"><surname>Norman</surname>, <given-names>S. B.</given-names></string-name>, <string-name name-style="western"><surname>Sonis</surname>, <given-names>J. H.</given-names></string-name>, <string-name name-style="western"><surname>Phelps</surname>, <given-names>A. J.</given-names></string-name>, <string-name name-style="western"><surname>Bisson</surname>, <given-names>J. I.</given-names></string-name>, <string-name name-style="western"><surname>Nunes</surname>, <given-names>V. D.</given-names></string-name>, <string-name name-style="western"><surname>Megnin-Viggars</surname>, <given-names>O.</given-names></string-name>, <string-name name-style="western"><surname>Forbes</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Riggs</surname>, <given-names>D. S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Schnurr</surname>, <given-names>P. P.</given-names></string-name></person-group> (<year>2019</year>). <article-title>A guide to guidelines for the treatment of posttraumatic stress disorder in adults: An update</article-title>. <source><italic toggle="yes">Psychotherapy</italic></source>, <volume><italic toggle="yes">56</italic></volume>(<issue>3</issue>), <fpage>359</fpage>&#8211;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1037/pst0000231</pub-id><pub-id pub-id-type="pmid">31282712</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Kessler</surname>, <given-names>R. C.</given-names></string-name>, <string-name name-style="western"><surname>Sonnega</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Bromet</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Hughes</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Nelson</surname>, <given-names>C. B.</given-names></string-name></person-group> (<year>1995</year>). <article-title>Posttraumatic stress disorder in the national comorbidity survey</article-title>. <source><italic toggle="yes">Archives of General Psychiatry</italic></source>, <volume><italic toggle="yes">52</italic></volume>(<issue>12</issue>), <fpage>1048</fpage>&#8211;<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1995.03950240066012</pub-id><pub-id pub-id-type="pmid">7492257</pub-id></mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Koenen</surname>, <given-names>K. C.</given-names></string-name>, <string-name name-style="western"><surname>Ratanatharathorn</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Ng</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>McLaughlin</surname>, <given-names>K. A.</given-names></string-name>, <string-name name-style="western"><surname>Bromet</surname>, <given-names>E. J.</given-names></string-name>, <string-name name-style="western"><surname>Stein</surname>, <given-names>D. J.</given-names></string-name>, <string-name name-style="western"><surname>Karam</surname>, <given-names>E. G.</given-names></string-name>, <string-name name-style="western"><surname>Meron Ruscio</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Benjet</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Scott</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Atwoli</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Petukhova</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Lim</surname>, <given-names>C. C.</given-names></string-name>, <string-name name-style="western"><surname>Aguilar-Gaxiola</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Al-Hamzawi</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Alonso</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Bunting</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Ciutan</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>de Girolamo</surname>, <given-names>G.</given-names></string-name>,&#8201;&#8230;&#8201;<string-name name-style="western"><surname>Kessler</surname>, <given-names>R. C.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Posttraumatic stress disorder in the world mental health surveys</article-title>. <source><italic toggle="yes">Psychological Medicine</italic></source>, <volume><italic toggle="yes">47</italic></volume>(<issue>13</issue>), <fpage>2260</fpage>&#8211;<lpage>2274</lpage>. <pub-id pub-id-type="doi">10.1017/S0033291717000708</pub-id><pub-id pub-id-type="pmid">28385165</pub-id><pub-id pub-id-type="pmcid">PMC6034513</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Larsen</surname>, <given-names>D. L.</given-names></string-name>, <string-name name-style="western"><surname>Attkisson</surname>, <given-names>C. C.</given-names></string-name>, <string-name name-style="western"><surname>Hargreaves</surname>, <given-names>W. A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Nguyen</surname>, <given-names>T. D.</given-names></string-name></person-group> (<year>1979</year>). <article-title>Assessment of client/patient satisfaction: Development of a general scale</article-title>. <source><italic toggle="yes">Evaluation and Program Planning</italic></source>, <volume><italic toggle="yes">2</italic></volume>(<issue>3</issue>), <fpage>197</fpage>&#8211;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/0149-7189(79)90094-6</pub-id><pub-id pub-id-type="pmid">10245370</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lewis</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname>, <given-names>N. P.</given-names></string-name>, <string-name name-style="western"><surname>Andrew</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Starling</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Bisson</surname>, <given-names>J. I.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Psychological therapies for post-traumatic stress disorder in adults: Systematic review and meta-analysis</article-title>. <source><italic toggle="yes">European Journal of Psychotraumatology</italic></source>, <volume><italic toggle="yes">11</italic></volume>(<issue>1</issue>), <fpage>1729633</fpage>. <pub-id pub-id-type="doi">10.1080/20008198.2020.1729633</pub-id><pub-id pub-id-type="pmid">32284821</pub-id><pub-id pub-id-type="pmcid">PMC7144187</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lewis</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname>, <given-names>N. P.</given-names></string-name>, <string-name name-style="western"><surname>Gibson</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Bisson</surname>, <given-names>J. I.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Dropout from psychological therapies for post-traumatic stress disorder (PTSD) in adults: Systematic review and meta-analysis</article-title>. <source><italic toggle="yes">European Journal of Psychotraumatology</italic></source>, <volume><italic toggle="yes">11</italic></volume>(<issue>1</issue>), <fpage>1709709</fpage>. <pub-id pub-id-type="doi">10.1080/20008198.2019.1709709</pub-id><pub-id pub-id-type="pmid">32284816</pub-id><pub-id pub-id-type="pmcid">PMC7144189</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maguen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Madden</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Holder</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Seal</surname>, <given-names>K. H.</given-names></string-name>, <string-name name-style="western"><surname>Neylan</surname>, <given-names>T. C.</given-names></string-name>, <string-name name-style="western"><surname>Lujan</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Patterson</surname>, <given-names>O. V.</given-names></string-name>, <string-name name-style="western"><surname>DuVall</surname>, <given-names>S. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Shiner</surname>, <given-names>B.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Effectiveness and comparative effectiveness of evidence-based psychotherapies for posttraumatic stress disorder in clinical practice</article-title>. <source><italic toggle="yes">Psychological Medicine</italic></source>, <volume><italic toggle="yes">53</italic></volume>(<issue>2</issue>), <fpage>419</fpage>&#8211;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1017/s0033291721001628</pub-id><pub-id pub-id-type="pmid">34001290</pub-id><pub-id pub-id-type="pmcid">PMC9899565</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Maguen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Madden</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Patterson</surname>, <given-names>O. V.</given-names></string-name>, <string-name name-style="western"><surname>DuVall</surname>, <given-names>S. L.</given-names></string-name>, <string-name name-style="western"><surname>Goldstein</surname>, <given-names>L. A.</given-names></string-name>, <string-name name-style="western"><surname>Burkman</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Shiner</surname>, <given-names>B.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Measuring use of evidence based psychotherapy for posttraumatic stress disorder in a large national healthcare system</article-title>. <source><italic toggle="yes">Administration and Policy in Mental Health and Mental Health Services Research</italic></source>, <volume><italic toggle="yes">45</italic></volume>(<issue>4</issue>), <fpage>519</fpage>&#8211;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1007/s10488-018-0850-5</pub-id><pub-id pub-id-type="pmid">29450781</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rabin</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>de Charro</surname>, <given-names>F.</given-names></string-name></person-group> (<year>2001</year>). <article-title>EQ-5D: A measure of health status from the EuroQol group</article-title>. <source><italic toggle="yes">Annals of Medicine</italic></source>, <volume><italic toggle="yes">33</italic></volume>(<issue>5</issue>), <fpage>337</fpage>&#8211;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.3109/07853890109002087</pub-id><pub-id pub-id-type="pmid">11491192</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sheehan</surname>, <given-names>D. V.</given-names></string-name>, <string-name name-style="western"><surname>Lecrubier</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Sheehan</surname>, <given-names>K. H.</given-names></string-name>, <string-name name-style="western"><surname>Amorim</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Janavs</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Weiller</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Hergueta</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Baker</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Dunbar</surname>, <given-names>G. C.</given-names></string-name></person-group> (<year>1998</year>). <article-title>The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10</article-title>. <source><italic toggle="yes">The Journal of Clinical psychiatry</italic></source>, <italic toggle="yes">59</italic>(Suppl 20), 22&#8211;57.<pub-id pub-id-type="pmid">9881538</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name name-style="western"><surname>Sloan</surname>, <given-names>D. M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Marx</surname>, <given-names>B. P.</given-names></string-name></person-group> (<year>2019</year>). <source><italic toggle="yes">Written exposure therapy for PTSD: A brief treatment approach for mental health professionals</italic></source>. <publisher-name>American Psychological Association</publisher-name>.</mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sloan</surname>, <given-names>D. M.</given-names></string-name>, <string-name name-style="western"><surname>Marx</surname>, <given-names>B. P.</given-names></string-name>, <string-name name-style="western"><surname>Acierno</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Messina</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Muzzy</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Gallagher</surname>, <given-names>M. W.</given-names></string-name>, <string-name name-style="western"><surname>Litwack</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Sloan</surname>, <given-names>C.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: A randomized clinical trial</article-title>. <source><italic toggle="yes">JAMA Psychiatry</italic></source>, <volume><italic toggle="yes">80</italic></volume>(<issue>11</issue>), <fpage>1093</fpage>&#8211;<lpage>1100</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2023.2810</pub-id><pub-id pub-id-type="pmid">37610727</pub-id><pub-id pub-id-type="pmcid">PMC10448372</pub-id></mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sloan</surname>, <given-names>D. M.</given-names></string-name>, <string-name name-style="western"><surname>Marx</surname>, <given-names>B. P.</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname>, <given-names>D. J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Resick</surname>, <given-names>P. A.</given-names></string-name></person-group> (<year>2018</year>). <article-title>A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: A randomized noninferiority clinical trial</article-title>. <source><italic toggle="yes">JAMA Psychiatry</italic></source>, <volume><italic toggle="yes">75</italic></volume>(<issue>3</issue>), <fpage>233</fpage>&#8211;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2017.4249</pub-id><pub-id pub-id-type="pmid">29344631</pub-id><pub-id pub-id-type="pmcid">PMC5843538</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sloan</surname>, <given-names>D. M.</given-names></string-name>, <string-name name-style="western"><surname>Marx</surname>, <given-names>B. P.</given-names></string-name>, <string-name name-style="western"><surname>Resick</surname>, <given-names>P. A.</given-names></string-name>, <string-name name-style="western"><surname>Young-McCaughan</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Dondanville</surname>, <given-names>K. A.</given-names></string-name>, <string-name name-style="western"><surname>Straud</surname>, <given-names>C. L.</given-names></string-name>, <string-name name-style="western"><surname>Mintz</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Litz</surname>, <given-names>B. T.</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname>, <given-names>A. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Consortium</surname>, <given-names>S. S.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Effect of written exposure therapy vs cognitive processing therapy on increasing treatment efficiency among military service members with posttraumatic stress disorder: A randomized noninferiority trial</article-title>. <source><italic toggle="yes">JAMA Network Open</italic></source>, <volume><italic toggle="yes">5</italic></volume>(<issue>1</issue>), <fpage>e2140911</fpage>&#8211;<lpage>e2140911</lpage>. <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.40911</pub-id><pub-id pub-id-type="pmid">35015065</pub-id><pub-id pub-id-type="pmcid">PMC8753496</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Smith</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Roche</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Loughlin</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Brennan</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Madigan</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Lyne</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Feeney</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>O&#8217;Donoghue</surname>, <given-names>B.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Satisfaction with services following voluntary and involuntary admission</article-title>. <source><italic toggle="yes">Journal of Mental Health</italic></source>, <volume><italic toggle="yes">23</italic></volume>(<issue>1</issue>), <fpage>38</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.3109/09638237.2013.841864</pub-id><pub-id pub-id-type="pmid">24484191</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Song</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Tomasson</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Arnberg</surname>, <given-names>F. K.</given-names></string-name>, <string-name name-style="western"><surname>Mataix-Cols</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Fernandez de la Cruz</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Almqvist</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Fall</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Valdimarsdottir</surname>, <given-names>U. A.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Association of stress-related disorders With subsequent autoimmune disease</article-title>. <source><italic toggle="yes">Jama</italic></source>, <volume><italic toggle="yes">319</italic></volume>(<issue>23</issue>), <fpage>2388</fpage>&#8211;<lpage>2400</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2018.7028</pub-id><pub-id pub-id-type="pmid">29922828</pub-id><pub-id pub-id-type="pmcid">PMC6583688</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Steinert</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Hofmann</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Leichsenring</surname>, <given-names>F.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Kruse</surname>, <given-names>J.</given-names></string-name></person-group> (<year>2015</year>). <article-title>The course of PTSD in naturalistic long-term studies: High variability of outcomes. A systematic review</article-title>. <source><italic toggle="yes">Nordic Journal of Psychiatry</italic></source>, <volume><italic toggle="yes">69</italic></volume>(<issue>7</issue>), <fpage>483</fpage>&#8211;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.3109/08039488.2015.1005023</pub-id><pub-id pub-id-type="pmid">25733025</pub-id></mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Svanborg</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Asberg</surname>, <given-names>M.</given-names></string-name></person-group> (<year>1994</year>). <article-title>A new self-rating scale for depression and anxiety states based on the comprehensive psychopathological rating scale</article-title>. <source><italic toggle="yes">Acta Psychiatrica Scandinavica</italic></source>, <volume><italic toggle="yes">89</italic></volume>(<issue>1</issue>), <fpage>21</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0447.1994.tb01480.x</pub-id><pub-id pub-id-type="pmid">8140903</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>